Parallel Advisors’s Clearside Biomedical CLSD Stock Holding History

Parallel Advisors’s Portfolio CLSD Stock Details CLSD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-133	Closed	-$10K	–	3092
2021 Q2	$10K	Hold	133	–	–	﹤0.01%	1987
2021 Q1	$5K	Hold	133	–	–	﹤0.01%	2167
2020 Q4	$5K	Hold	133	–	–	﹤0.01%	2017
2020 Q3	$3K	Hold	133	–	–	﹤0.01%	2175
2020 Q2	$3K	Hold	133	–	–	﹤0.01%	2070
2020 Q1	$3K	Hold	133	–	–	﹤0.01%	2016
2019 Q4	$6K	Sell	133 -4,073	-97%	-$85.6K	﹤0.01%	1898
2019 Q3	$40K	Buy	4,206 +6	+0.1%	+$86	﹤0.01%	1074
2019 Q2	$61K	Hold	4,200	–	–	0.01%	837
2019 Q1	$87K	Buy	+4,200	New	+$83.3K	0.01%	654

Other funds holding CLSD

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return

ACM

ACT Capital Management Wayne, Pennsylvania $153M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parallel Advisors's CLSD Position: Q3 2021 in Review

Parallel Advisors sold out of Clearside Biomedical (CLSD) in Q3 2021, closing a stake of 133 shares — an estimated $10K sold.

Parallel Advisors first reported a position in CLSD in Q1 2019 and held it in 10 quarters. The position peaked at $87K in Q1 2019. 65 funds tracked by Wall St. Rank hold CLSD as of Q3 2021.

Parallel Advisors reported no remaining Clearside Biomedical position as of Q3 2021 after selling out during the quarter.
Parallel Advisors sold 133 Clearside Biomedical shares in Q3 2021, an estimated $10K.
Parallel Advisors first reported a position in Clearside Biomedical in Q1 2019 and held it in 10 quarters.
Parallel Advisors's Clearside Biomedical position peaked at $87K in Q1 2019.
65 funds tracked by Wall St. Rank held Clearside Biomedical as of Q3 2021.

Based on Parallel Advisors's 13F filing for Q3 2021, filed 22 Oct 2021.